XML 113 R20.htm IDEA: XBRL DOCUMENT v2.4.0.6
EQUITY
12 Months Ended
Dec. 31, 2012
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
NOTE 13:- EQUITY

 

a. Treasury stock:

 

In October 2011, the Company's Board of Directors approved a share repurchase plan pursuant to which the Company was authorized to purchase up to 4,000,000 of its outstanding ordinary shares. During the year ended December 31, 2011 and 2012, the Company purchased 1,204,757 and 2,759,594 of its outstanding ordinary shares under this share repurchase plan, at a weighted average price per share of $ 3.33 and $ 2.44, respectively. As of October 2012, the authorized stock repurchase program was completed.

 

b. Warrants issued to nonemployees:

 

During the years ended December 31, 2010, 2011 and 2012, the Company granted warrants to purchase 25,000, 2,500 and 4,000 shares at a weighted average exercise price of $ 2.92, $ 3.57 and $ 3.89 per share, respectively, in each case expiring seven years from the date of grant. The Company recorded immaterial compensation expenses with respect to the grants of these warrants in accordance with ASC 505. During the year ended December 31, 2010, 5,000 warrants were exercised and during the year ended December 31, 2012, 10,000 warrants were forfeited. As of December 31, 2011 and 2012, 32,500 and 26,500 warrants issued to consultants are outstanding, out of which 17,500 and 22,500 warrants are exercisable, respectively.

  

c. Employee Stock Purchase Plan:

 

In May 2001, the Company's Board of Directors adopted the Employee Stock Purchase Plan ("ESPP" or "the Purchase Plan"), which was amended, in July 2007. The Purchase Plan, as amended, provides for the issuance of up to 6,500,000 ordinary shares. As of December 31, 2011, 1,761,317 shares were available for future issuance under the Purchase Plan. Eligible employees can have up to 10% of their wages, up to certain maximums, used to purchase ordinary shares. The Purchase Plan is implemented with purchases every six months. The price of the ordinary shares purchased under the

 

Purchase Plan is equal to 85% of the lower of the fair market value of the ordinary shares on the commencement date of each offering period or on the semi-annual purchase date. The Purchase Plan is considered a compensatory plan. Therefore, the Company records compensation expense in accordance with ASC 718, "Compensation - Stock Compensation", with respect to purchases under the Purchase Plan.

 

During the year ended December 31, 2011, 288,515 shares were issued under the Purchase Plan for aggregate consideration of $ 1,187. As of December 31, 2011 and 2012, the Company's Board of Directors decided to suspend the Purchase Plan for the employees of the Company's U.S subsidiary and the Purchase Plan for the Company and its non-U.S subsidiaries has expired.

 

d. Employee Stock Option Plans:

 

In the year ended December 31, 2008, the Company's Board of Directors approved the 2008 Equity Incentive Plan that became effective in January 2009. As of December 31, 2012, the total number of shares authorized for grant under this Plan is 660,979.

 

Stock options granted under the abovementioned plan are exercisable at the fair market value of the ordinary shares at the date of grant and usually expire seven or ten years from the date of grant. The options generally vest over four years from the date of grant. Any options that are forfeited or cancelled before expiration become available for future grants.

  

The following is a summary of the Company's stock option activity and related information for the year ended December 31, 2012:

 

    Amount
of options
    Weighted
average
exercise
price
    Weighted
average
remaining
contractual
term (in
years)
    Aggregate
intrinsic
value
 
                         
Outstanding at beginning of year     3,894,556     $ 6.10       4.2     $ 1,824  
Changes during the year:                                
Granted     927,376     $ 2.66                  
Exercised     (52,125 )   $ 1.97                  
Forfeited     (540,375 )   $ 6.72                  
Expired     (452,400 )   $ 10.16                  
                                 
Options outstanding at end of year     3,777,032     $ 4.74       4.0     $ 1,477  
                                 
Vested and expected to vest     3,569,295     $ 4.74       4.0     $ 1,396  
                                 
Options exercisable at end of year     2,098,152     $ 5.85       2.5     $ 753  

 

The weighted-average grant-date fair value of options granted during the years ended December 31, 2010, 2011 and 2012 was $ 1.96, $ 2.69 and $ 1.35, respectively. The aggregate intrinsic value in the table above represents the total intrinsic value (the difference between the Company's closing stock price on the last trading day of the fiscal year and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on the last trading day of the fiscal year. This amount changes based on the fair market value of the Company's shares.

 

Total intrinsic value of options exercised for the years ended December 31, 2010, 2011 and 2012 was $ 2,946, $ 44 and $ 63, respectively.

  

The options outstanding as of December 31, 2012, have been separated into ranges of exercise prices, as follows:

 

Range of
exercise
price
    Options
outstanding
 as of 
December 31,
2012
    Weighted 
average 
remaining
contractual
 life
  Weighted
average
exercise 
price
    Options
exercisable 
as of 
December 31,
2012
    Weighted
average
exercise price
of exercisable
options
 
            (Years)                  
                               
$ 0.00-1.10       50,816     4.53   $ 0.01       49,691     $ 0.01  
$ 1.50-2.51       751,625     4.34   $ 2.03       420,875     $ 2.09  
$ 2.57-4.00       1,377,885     5.79   $ 3.04       337,649     $ 3.06  
$ 4.08-6.49       842,956     3.16   $ 5.51       634,812     $ 5.57  
$ 6.51-9.24       153,750     4.52   $ 7.30       55,125     $ 7.13  
$ 9.32-14.76       600,000     0.56   $ 10.70       600,000     $ 10.70  
                                         
          3,777,032     4.0   $ 4.74       2,098,152     $ 5.85  

 

The following is a summary of the Company's restricted share units ("RSUs") activity and related information for the year ended December 31, 2012:

 

    Number of
shares
    Weighted
average grant
date fair value
 
             
Outstanding at beginning of year     264,684     $ 4.89  
Changes during the year:                
Granted     70,215     $ 2.73  
Exercised     (120,488 )   $ 4.97  
Forfeited     (32,250 )   $ 6.10  
                 
RSUs outstanding at end of year     182,161     $ 3.79  

 

During the years ended December 31, 2010, 2011 and 2012, the share based compensation expenses related to the RSUs granted amounted to $ 678, $ 786 and $ 435, respectively.

 

As of December 31, 2012, there was $ 2,020 of total unrecognized compensation cost related to non-vested share-based compensation arrangements granted under the Company's stock option plans. That cost is expected to be recognized over a weighted-average period of 1.08 years.

 

e. Dividends:

 

In the event that cash dividends are declared in the future, such dividends will be paid in NIS. The Company does not intend to pay cash dividends in the foreseeable future. (See also Note 14a.)